62 Stocks Moving In Friday's Mid-Day Session

Gainers
 

• Genetic Technologies Limited GENE shares surged 69 percent to $1.19 after the company announced the successful completion of two new groundbreaking genetic risk tests for colorectal cancer and breast cancer.
• Jiayin Group Inc. JFIN rose 36.8 percent to $14.36. Jiayin Group priced its 3.5 million ADS IPO at $10.50 per ADS.
• Buckeye Partners, L.P. BPL gained 28.4 percent to $41.81 after the company announced it will be acquired by IFM Investors for $41.50 per unit.
• Cool Holdings, Inc. AWSM gained 26.4 percent to $2.92 after announcing plans to buy Simply Mac from GameStop Corp GME.
• G1 Therapeutics Inc GTHX gained 24.2 percent to $25.69 after the company announced plans to submit US and European marketing applications for its Trilaciclib.
• Cardlytics Inc CDLX gained 23.5 percent to $20.83 after the company reported better-than-expected Q1 EPS and provided Q2 sales guidance above analyst estimates.
• Creative Realities, Inc. CREX rose 20 percent to $2.8632 after reporting Q1 results.
• Avedro, Inc. AVDR climbed 18.7 percent to $14.99 following upbeat Q1 earnings.
• Guardant Health Inc GH shares rose 17.2 percent to $75.09 after the company reported better-than-expected Q1 EPS and sales results. The company also raised FY19 sales guidance.
• Basic Energy Services, Inc. BAS gained 15.3 percent to $2.8354 following strong quarterly earnings.
• Evofem Biosciences, Inc. EVFM rose 14.4 percent to $6.58.
• SunPower Corporation SPWR rose 13.8 percent to $8.40 following Q1 results.
• Village Farms International, Inc. VFF gained 13.6 percent to $12.51 after the company reported Q1 EPS and sales numbers up from last year.
• Natera Inc NTRA surged 13.6 percent to $20.17 after the company reported better-than-expected Q1 EPS and sales results. The company also issued FY19 sales guidance above analyst estimates.
• Social Reality, Inc. SRAX gained 12.1 percent to $4.6870.
• Calumet Specialty Products Partners, L.P. CLMT rose 11.4 percent to $4.02 following strong Q1 results.
• Noodles & Co NDLS gained 11 percent to $8.50 after the company reported better-than-expected Q1 EPS and sales results; the company also issued FY19 sales guidance above analyst estimates.
• Vista Outdoor Inc. VSTO surged 10.8 percent to $10.24 after Monness Crespi Hardt upgraded the company's stock from Neutral to Buy.
• ShockWave Medical, Inc. SWAV rose 10.1 percent to $53.58.
• The Joint Corp. JYNT gained 9.7 percent to $19.08 following upbeat Q1 results.
• GP Strategies Corporation GPX surged 9.1 percent to $14.24 after reporting strong Q1 results.
• Zillow Group Inc ZG rose 8.9 percent to $36.54 after reporting a first-quarter sales beat.
• Pintec Technology Holdings Limited PT surged 8.8 percent to $8.16.
• Pieris Pharmaceuticals, Inc. PIRS rose 8.8 percent to $3.47 following Q1 results.
• Construction Partners, Inc. ROAD surged 8.6 percent to $12.19 following Q2 results.
• Dyadic International, Inc. DYAI gained 7.5 percent to $4.19 after the company reported Q1 sales up from last year.
• Beigene Ltd BGNE gained 6.2 percent to $128.70 after the company reported better-than-expected Q1 EPS and sales.
• News Corp NWSA gained 4 percent to $11.88 after the company reported better-than-expected Q3 EPS results.

Check out these big penny stock gainers and losers

Losers

• Transenterix Inc TRXC tumbled 38.3 percent to $1.2950 after the company reported worse-than-expected Q1 EPS and sales results.
• Puma Biotechnology, Inc. PBYI dropped 38 percent to $18.60 after the company reported Q1 Nerlynx sales decline from last quarter due to an increase in patients discontinuing treatment. Cantor Fitzgerald downgraded Puma Biotechnology from Overweight to Neutral and lowered the price target from $57 to $20.
• Pro-Dex, Inc. PDEX fell 30.5 percent to $12.41.
• Qurate Retail Inc QRTEA shares tumbled 29.3 percent to $11.74 after the company reported Q1 EPS and sales down from last year.
• FibroGen, Inc. FGEN fell 25.4 percent to $34.09 after the company reported Q1 results and disclosed results from a study of roxadustat. A STAT News article suggested the company's "obtuse disclosure" raised concerns about heart safety with the candidate. William Blair downgraded FibroGen from Outperform to Market Perform.
• Jumia Technologies AG JMIA fell 24.9 percent to $20.20 on continued weakness after short seller Citron Research on Thursday called the company an 'Obvious Fraud'.
• Melinta Therapeutics Inc MLNT fell 23.8 percent to $3.53 after the company reported Q1 results. Jefferies downgraded Melinta Therapeutics from Buy to Hold and lowered the price target from $14 to $5.
• inTEST Corporation INTT declined 21.4 percent to $5.24 after the company reported downbeat Q1 results and issued weak Q2 forecast.
• Aqua Metals Inc AQMS fell 20.4 percent to $2.0459 after the company reported worse-than-expected Q1 EPS results. Aqua Metals priced its 11 million share common stock offering at $2 per share.
• Marin Software Incorporated MRIN dropped 20.2 percent to $4.47 following Q1 results.
• JAKKS Pacific, Inc JAKK tumbled 19 percent to $0.83 after the company reported worse-than-expected Q1 EPS and sales results.
• Zovio Inc ZVO dipped 17.9 percent to $4.8350 after the company reported Q1 EPS and sales down from last year.
• Yelp Inc YELP dropped 16.1 percent to $33.35 after the company reported worse-than-expected Q1 earnings results and the stock was downgraded by B. Riley from Buy to Neutral.
• Symantec Corporation SYMC fell 15.2 percent to $18.81 after the company reported downbeat sales for its fourth quarter and issued Q1 earnings guidance below analyst estimates. Symantec disclosed that its President and CEO Greg Clark is stepping down.
• Sensus Healthcare, Inc. SRTS dropped 15 percent to $5.45 after the company reported worse-than-expected Q1 EPS and sales results.
• LightPath Technologies, Inc. LPTH dipped 15 percent to $1.28 after the company reported Q3 EPS down from last year and worse-than-expected Q3 sales results.
• Forescout Technologies, Inc. FSCT slipped 14.6 percent to $36.97 after the company reported strong Q1 results but issued Q2 sales guidance below analyst estimates.
• Shotspotter Inc SSTI dropped 14.1 percent to $47.15 after the company reported worse-than-expected Q1 financial results and cut its 2019 sales guidance.
• ARCA biopharma, Inc. ABIO fell 14 percent to $13.00.
• Atomera Incorporated ATOM fell 13.5 percent to $3.46.
• TrueCar, Inc. TRUE fell 13.1 percent to $6.26 after the company issued Q2 sales guidance below analyst estimates. The company also lowered FY19 sales guidance.
• 51job, Inc. JOBS dipped 11.6 percent to $74.47 after the company reported worse-than-expected Q1 sales results.
• Momo Inc. MOMO fell 11.5 percent to $28.59 after the company announced it will temporarily prevent users from posting 'social newsfeeds' on its platform as the company conducts internal reviews to strengthen content screening.
• Greenlane Holdings, Inc. GNLN dropped 10.3 percent to $15.50 following Q1 results.
• Ubiquiti Networks Inc UBNT dipped 9.9 percent to $140.90 after the company reported worse-than-expected Q3 sales results.
• Innodata Inc INOD dropped 9.7 percent to $1.03 after the company reported Q1 EPS and sales down year-over-year.
• Senseonics Holdings Inc SENS fell 9.5 percent to $2.14 after the company reported worse-than-expected Q1 EPS results.
• EXACT Sciences Corporation EXAS dropped 9.5 percent to $92.50 after Guardant Health announced positive data for a competing product.
• Wynn Resorts, Limited WYNN dropped 6.8 percent to $127.1 after the company reported worse-than-expected Q1 sales results.
• Airgain Inc AIRG dropped 6.7 percent to $14.66 after the company issued Q2 sales guidance below analyst estimates, offsetting better-than-expected Q1 EPS and sales results
• Nevro Corp. NVRO fell 6.5 percent to $58.71 after the company reported worse-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance below analyst estimates.
• Ritchie Bros. Auctioneers Inc RBA dropped 6.3 percent to $32.44 after the company reported mixed Q1 financial results.
• Jagged Peak Energy Inc JAG dipped 6 percent to $10.42 after the company reported worse-than-expected Q1 EPS and sales results.
• Concrete Pumping Holdings Inc BBCP dropped 5.3 percent to $4.62 after the company priced 16 million shares at $4.50 per share.